Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 18, 2014
Grant Date -
Feb 28, 2008
app pub date -
Apr 20, 2007
filing date -
Sep 4, 2002
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
In its many embodiments, the present invention provides a method of inhibiting one or more cyclin dependent kinases in a patient comprising administering to said patient a therapeutically effective amount of at least one pyrazolo[1,5-a]pyrimidine compound or a pharmaceutical composition comprising such compound, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions. An example pyrazolo[1,5-a]pyrimidine compound useful in the present invention is shown below:
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully